Pathophysiology of overactive bladder and urge urinary incontinence

William D Steers, William D Steers

Abstract

Storage symptoms such as urgency, frequency, and nocturia, with or without urge incontinence, are characterized as overactive bladder (OAB). OAB can lead to urge incontinence. Disturbances in nerves, smooth muscle, and urothelium can cause this condition. In some respects the division between peripheral and central causes of OAB is artificial, but it remains a useful paradigm for appreciating the interactions between different tissues. Models have been developed to mimic the OAB associated with bladder instability, lower urinary tract obstruction, neuropathic disorders, diabetes, and interstitial cystitis. These models share the common features of increased connectivity and excitability of both detrusor smooth muscle and nerves. Increased excitability and connectivity of nerves involved in micturition rely on growth factors that orchestrate neural plasticity. Neurotransmitters, prostaglandins, and growth factors, such as nerve growth factor, provide mechanisms for bidirectional communication between muscle or urothelium and nerve, leading to OAB with or without urge incontinence.

Figures

Figure 1
Figure 1
Bladder smooth muscle from patients in unstable bladder demonstrates increased myogenic activity, with fused tetanic contractions and changes in structure. Increased connective tissue between muscle fascicles is reminiscent of that seen with aging, obstruction, and apoptosis due to ischemia. Thus, myogenic changes are commonly seen in the OAB with or without urge incontinence. Reprinted from Morrison J, Steers WD, Brading A, et al. Neurophysiology and neuropharmacology. In: Khoury S, Abrams P, Wein A (eds). Incontinence, 2nd ed. Plymouth, UK: Health Publication Ltd; 2002.
Figure 2
Figure 2
Altered responses to stimuli occur in unstable bladders. Obstructed bladders demonstrate hypersensitivity to cholinergic agonists acting at muscarinic (M2 or M3) receptors and increased contractions due to potassium chloride, but reduced electrical evoked contractions. Detrusor tissue from idiopathic instability patients shows increased electrical evoked contractions but normal sensitivity to muscarinic agonists (M3 and M2). Denervated bladders show increased M3 receptor expression. Acetylcholine released from parasympathetic nerves supplying the bladder cause activation of M3 receptors responsible for bladder contraction in humans. The M3 elicited contraction is due to a rise in cytosolic calcium (Ca+2) from intracellular stores. Ca+2 is released from these stores following M3-coupled activation of G-protein (G-p) mediated phospholipase C (PLC) breakdown. Inositol triphosphate (IP3) triggers Ca+2 release from sacroplasmic reticulum (SR). M2 activation causes a fall in cyclic adenosine monophosphate (cAMP), preventing relaxation. Newer anticholinergics selectively target M3 receptors in the hope of reducing side effects and perhaps increasing efficacy. Reprinted from Morrison J, Steers WD, Brading A, et al. Neurophysiology and neuropharmacology. In: Khoury S, Abrams P, Wein A (eds). Incontinence, 2nd ed. Plymouth, UK: Health Publication Ltd; 2002.
Figure 3
Figure 3
The urothelium directly communicates with suburothelial afferents acting as luminal sensors. Increased sensitivity of these afferents may lead to overactive bladder (OAB). Low pH, high potassium concentration in the urine, and increased osmolality can influence sensory nerves through mediators such as nitric oxide (NO) and neurokinin A, which acts through NK-2 receptors. H+ ions activate vanilloid (VR-1) receptors, causing pain. Adenosine triphosphate (ATP) can activate purinergic P2X3 receptors and modulate sensation. Mice lacking the P2X3 receptor exhibit enlarged bladders and reduced sensation. Inflammatory cytokines and nerve growth factor (NGF) acting at tyrosine kinase A (trk A) receptors can influence the growth, transmitter synthesis, and function of neurons. Sensitization of suburothelial afferents without changes in smooth muscle may result only in urgency. If afferents are sensitized (lower thresholds, spontaneous burst firing) and smooth muscle coupling is enhanced, urgency with unstable contractions may result. Vanilloid, neurokinin, and purinergic antagonists are being examined as possible therapies for OAB and urge incontinence. Reprinted from Morrison J, Steers WD, Brading A, et al. Neurophysiology and neuropharmacology. In: Khoury S, Abrams P, Wein A (eds). Incontinence, 2nd ed. Plymouth, UK: Health Publication Ltd; 2002.
Figure 4
Figure 4
Sensitization of bladder afferents such as occurs following obstruction or inflammation may lead to enhanced transmission involving second-order neurons in the sacral spinal cord. If preganglionic neurons are not activated, then urgency and frequency without unstable contractions may result. Reprinted from Morrison J, Steers WD, Brading A, et al. Neurophysiology and neuropharmacology. In: Khoury S, Abrams P, Wein A (eds). Incontinence, 2nd ed. Plymouth, UK: Health Publication Ltd; 2002.
Figure 5
Figure 5
After transient environmental (ie, intravesical) changes such as inflammation or temporary obstruction, afferents may revert to normal activity. However, if patient is genomically predisposed to OAB (eg, exhibits familial urge incontinence or chronic pain syndromes such as interstitial cystitis, irritable bowel syndrome, or fibromyalgia) or long-term environmental changes occur, nerve growth factor (NGF) may alter afferents irreversibly. Antibody to NGF or fusion protein against the NGF receptor prevents overactive bladder (OAB) in animal models coincident with alterations in afferents. NGF’s long-term actions may rely on changes in sodium (Na+) channel isoforms expressed by afferents that influence excitability. Most unmyelinated (C-fiber) afferents are not responsive to normal stimuli such as distention or presence of intravesical contents. However, following spinal cord injury, obstruction, or inflammation, activation of the silent C-fibers occurs. The reawakening of silent C-fibers may correspond to changes in Na+ channel expression. Novel approaches to OAB in the future may target the mechanisms leading to these long-term changes. Reprinted from Morrison J, Steers WD, Brading A, et al. Neurophysiology and neuropharmacology. In: Khoury S, Abrams P, Wein A (eds). Incontinence, 2nd ed. Plymouth, UK: Health Publication Ltd; 2002.

References

    1. Eckhardt MD, van Venrooij GE, Boon TA. Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia. Urology. 2001;58:966–971.
    1. Sibley GNA. The Response of the Bladder to Lower Urinary Tract Obstruction [DM thesis] Oxford, England: Oxford University; 1984.
    1. German K, Bedwani J, Davies J, et al. What is the pathophysiology of detrusor hyperreflexia? Neurourol Urodyn. 1993;12:335–336.
    1. Sibley GNA. Developments in our understanding of detrusor instability. Br J Urol. 1997;80:54–61.
    1. Brading AF, Turner WH. The unstable bladder: towards a common mechanism. Br J Urol. 1994;73:3–8.
    1. Mills IW. The Pathophysiology of Detrusor Instability and the Role of Bladder Ischemia in Its Etiology [DM thesis] Oxford, England: Oxford University; 1999.
    1. German K, Bedwani J, Davies J, et al. Physiological and morphometric studies into the pathophysiology of detrusor hyperreflexia in neuropathic patients. J Urol. 1995;153:1678–1683.
    1. Brading AF, Speakman MJ. Pathophysiology of bladder outflow obstruction. In: Whitfield H, Kirby R, Hendry WF, Duckett J, editors. Textbook of Genitourinary Surgery. Oxford: Blackwell Science; 1998. pp. 465–479.
    1. Charlton RG, Morley AR, Chambers P, et al. Focal changes in nerve, muscle and connective tissue in normal and unstable human bladder. Br J Urol. 1999;84:953–960.
    1. Schröoder A, Chichester P, Kogan BA, et al. Effect of chronic bladder outlet obstruction on the blood flow of the rabbit urinary bladder. J Urol. 2001;165:640–646.
    1. Levin RM, Haugaard N, Hypolite JA, et al. Metabolic factors influencing lower urinary tract function. Exp Physiol. 1999;84:171–194.
    1. Steers WD, Ciambotti J, Etzel B, et al. Alterations in afferent pathways from the urinary bladder of the rat in response to partial urethral obstruction. J Comp Neurol. 1991;310:401–410.
    1. Steers WD, Ciambotti J, Erdman S, et al. Morphological plasticity in efferent pathways to the urinary bladder of the rat following urethral obstruction. J Neurosci. 1990;10:1943–1951.
    1. Gabella G, Berggren T, Uvelius B. Hypertrophy and reversal of hypertrophy in rat pelvic ganglion neurons. J Neurocytol. 1992;21:649–662.
    1. Kruse MN, Belton AL, de Groat WC. Changes in bladder and external sphincter function after spinal injury in the rat. Am J Physiol. 1993;264:1157–1163.
    1. de Groat WC. A neurological basis for the overactive bladder. Urology. 1997;50:36–52.
    1. Geirrson G, Lindstrom S, Fall M. The bladder cooling reflex in man—characteristics and sensitivity to temperature. Br J Urol. 1993;71:675–680.
    1. Geirsson G, Lindstrom S, Fall M. The bladder cooling reflex and the use of cooling as stimulus to the lower urinary tract. J Urol. 1999;162:1890–1896.
    1. Dasgupta P, Chandiramani VA, Beckett A, et al. The effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyper-reflexia. BJU Int. 2000;85:238–245.
    1. Morrison JFB. Sensations arising from the lower urinary tract. In: Torrens M, Morrison JFB, editors. The Physiology of the Lower Urinary Tract. Berlin: Springer-Verlag; 1987. pp. 89–131.
    1. Namasivayam S, Eardley I, Morrison JFB. A novel in vitro bladder-pelvic nerve afferent model in the rat. Br J Urol. 1998;82:902–905.
    1. Coolsaet BL, Van Duyl WA, Van Os-Bossagh P, et al. New concepts in relation to urge and detrusor activity. Neurourol Urodyn. 1993;12:463–471.
    1. Porreca F, Lai J, Bian D, et al. A comparison of the potential role of the tetrodotoxin-insensitive channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc Natl Acad Sci U S A. 1999;96:7640–7644.
    1. Yoshimura N, de Groat WC. Plasticity of Na+ channels in afferent neurones innervating rat urinary bladder following spinal cord injury. J Physiol. 1997;503(Pt 2):269–276.
    1. Bennett DL, Dmietrieva N, Priestley JV, et al. trkA, CGRP and IB4 expression in retrogradely labelled cutaneous and visceral primary sensory neurons in the rat. Neurosci Lett. 1996;206:33–36.
    1. Chai T, Gray M, Steers WD. The incidence of a positive ice water test in bladder outlet obstructed patients: evidence for bladder neuroplasticity. J Urol. 1998;160:34.
    1. Yoshimura N, Erdman S, Snider W, de Groat WC. Effects of spinal cord injury or neurofilament immunoreactivity and capsaicin sensitivity in rat dorsal root ganglion neurons innervating the urinary bladder. Neuroscience. 1998;83:633–643.
    1. Lee KS, Dean-McKinney T, Tuttle JB, Steers WD. Intrathecal antisense oligonucleotide against the gene for the tetrodotoxin-resistant sodium channel (Nav1.8) reduces bladder hyperactivity in obstructed rats [abstract] J Urol. 2002;167:34A.
    1. Lee KS, Dean-McKinney T, Tuttle JB, Steers WD. Intrathecal antisense oligonucleotides against the tetrodotoxin-resistant sodium channel reduces bladder hyperactivity in the spontaneously hypertensive rat [abstract] J Urol. 2002;167:38A.
    1. Edlund C, Peeker R, Fall M. Lidocaine cystometry in the diagnosis of bladder overactivity. Neurourol Urodyn. 2001;20:147–155.
    1. Castleden CM, Duffin HM, Clarkson EJ. In vivo and in vitro studies on the effect of sodium antagonists on the bladder in man and rat. Age Ageing. 1983;12:249–255.
    1. Lapointe SP, Wang B, Kennedy WA, Shortliffe LM. The effects of intravesical lidocaine on bladder dynamics of children with myelomeningocele. J Urol. 2001;165:2380.
    1. Yokoyama O, Komatsu K, Kodama K, et al. Diagnostic value of intravesical lidocaine for overactive bladder. J Urol. 2000;164:340–343.
    1. Reuther K, Aagaard J, Jensen KS. Lignocaine test and detrusor instability. Br J Urol. 1983;55:493–494.
    1. Levin RM, Hypolite J, Longhurst PA, Wein AJ. Comparison of the contractile and metabolic effects of muscarinic stimulation with those of KCl. Pharmacology. 1991;42:142–150.
    1. Lecci A, Giuliani S, Lazzeri M, et al. The behavioral response induced by intravesical instillation of capsaicin rats is mediated by pudendal urethral sensory fibers. Life Sci. 1994;55:429–436.
    1. Kamphuis ET, Ionescu TI, Kuipers PW, et al. Recovery of storage and emptying functions of the urinary bladder after spinal anesthesia with lidocaine and with bupivacaine in men. Anesthesiology. 1998;88:310–316.
    1. Steers WD, Tuttle JB. Immunity to NGF prevents afferent plasticity in the spinal cord following hypertrophy of the bladder. J Urol. 1996;155:379–385.
    1. Steers WD, Ciambotti J, Erdman S, de Groat W. Morphological plasticity in efferent pathways to the urinary bladder of the rat following urethral obstruction. J Neurosci. 1990;10:1943–1951.
    1. Chai T, Baker L, Gomez A, et al. Hyperactive voiding in rats secondary to obstruction and relief of obstruction: expression of a novel gene encoding for protein D123 [abstract] J Urol. 1997;157:349A.
    1. Steers WD, Kolbeck S, Creedon D, Tuttle JB. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest. 1991;88:1709.
    1. Ishizuka O, Mattiasson A, Steers WD, Andersson K-E. Effects of spinal alpha-1-adrenoceptor antagonism on bladder activity induced by apomorphine in conscious rats with and without bladder outlet obstruction. Neurourol Urodyn. 1997;16:191.
    1. Tanner R, Chambers P, Khadra MH, Gillespie JI. The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro. BJU Int. 2000;85:1115–1119.
    1. Steers WD, Tuttle JB. Neurogenic inflammation and nerve growth factor: possible roles in interstitial cystitis. In: Sant GR, editor. Interstitial Cystitis. Philadelphia, PA: Lippincott-Raven; 1997. pp. 67–75.
    1. Lowe EM, Anand P, Terenghi G, et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol. 1997;79:572–577.
    1. Dupont MC, Spitsbergen JM, Kim KB, et al. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol. 2001;166:1111–1118.
    1. Bjorling DE, Jacobsen HE, Blum JR, et al. Intravesical Escherichia coli lipopolysaccharide stimulates an increase in bladder nerve growth factor. BJU Int. 2001;87:697–702.
    1. Vizzard MA, Erdman SL, de Groat WC. Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation. J Comp Neurol. 1996;370:191.
    1. Dupont M, Steers W, Tuttle JB. Inflammation induced neural plasticity in autonomic pathways supplying the bladder depends on NGF. Abstr Soc Neurosci. 1994;20:112.
    1. Birder LA, Kanai A, Truschel S, et al. Measurement of adrenergic and capsaicin evoked nitric oxide release from urinary bladder epithelium using a porphyrinic microsensor. FASEB Abstr. 1998;98:A122.
    1. Morrison JFB, Namasivayam S, Eardley I. ATP may be a natural modulator of the sensitivity of bladder mechanoreceptors during slow distensions. 1st International Consultation on Incontinence. In: Khoury S, Abrams P, Wein A, editors. Incontinence. Plymouth, UK: Plymouth Distr. Ltd; 1999. p. 84.
    1. Bean BP, Williams CA, Ceelen PW. ATP-activated channels in rat and bullfrog sensory neurons: current-voltage relation and single channel behavior. J Neurosci. 1990;10:11.
    1. Clemow D, McCarty R, Steers W, Tuttle JB. Efferent and afferent neuronal hypertrophy associated with micturition pathways in spontaneously hypertensive rats. Neurourol Urodyn. 1997;16:293–303.
    1. Aguayo LG, White G. Effects of nerve growth factor on TTX- and capsaicin-sensitivity in adult rat sensory neurons. Brain Res. 1992;570:61–70.
    1. Geirsson G. Evidence for cold receptors in the human urinary bladder: effect of menthol on the bladder cooling reflex. J Urol. 1993;150:427–431.
    1. Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol. 2001;63:871–894.
    1. Kruse M, Bray L, de Groat W. Influence of spinal cord injury on the morphology of bladder afferent and efferent neurons. J Auton Nerv Syst. 1995;54:215–223.
    1. Yoshimura N, de Groat W. Plasticity of Na channels in afferent neurons innervating the rat urinary bladder following spinal cord injury. J Physiol. 1997;503:269–276.
    1. Wolfe F, Russell IJ, Vipraio G, et al. Serotonin levels, pain threshold, and fibromyalgia, symptoms in the general population. J Rheumatol. 1997;24:555–559.
    1. O’Malley PG, Jackson JL, Santoro J, et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract. 1999;48:980–990.
    1. Neeck G. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand J Rheumatol Suppl. 2000;113:8–12.
    1. Bondy B, Spaeth M, Offenbaecher M, et al. The T102C polymorphism of the 5-HT2A receptor gene in fibromyalgia. Neurobiol Dis. 1999;6:433–439.
    1. Offenbaecher M, Bondy B, de Jonge S, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 1999;42:2482–2488.
    1. Collier DA, Stober G, Li T, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1:453–460.
    1. Roy A. Suicidal behavior in depression: relationship to platelet serotonin transporter. Neuropsychobiology. 1999;39:71–75.
    1. McMahon SB, Spillane K. Brainstem influences on the para-sympathetic supply to the urinary bladder of the cat. Brain Res. 1982;234:237–249.
    1. Downie JW. Pharmacological manipulation of central micturition circuitry. Curr Opin CPNS Invest Drugs. 1999;12:231–239.
    1. Espey MJ, Downie JW. Serotonergic modulation of cat bladder function before and after spinal transection. Eur J Pharmacol. 1995;287:173–177.
    1. Steers WD, Albo M, van Asselt E. Effects of serotonergic agonists on micturition function in the rat. Drug Dev Res. 1992;27:361–375.
    1. Steers WD, de Groat WC. Effects of m-chlorophenylpiperazine on penile and bladder function in rats. Am J Physiol. 1989;257:R1441–R1449.
    1. Zorn BH, Montgomery H, Pieper K, et al. Urinary incontinence and depression. J Urol. 1999;162:82–84.
    1. Melville J, Lentz G, Millier J, Fenner D. Impact of depression on symptom perceptions, quality of life and functional status. Abstract presented at the 2001 meeting of the American Urogynecologic Society; October 25–27, 2001; Chicago, IL.
    1. Boyle P, Napalkov P. The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension. Scand J Urol Nephrol. 1995;168:7–12.
    1. Weissman MM, Fyer AJ, Haghighi F, et al. Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet. 2000;96:24–35.
    1. Bhatia MS, Nigam VR, Bohra N, Malik SC. Attention deficit disorder with hyperactivity among pediatric outpatients. J Child Psychol Psychiatry. 1991;32:297–306.
    1. Archer JS. NAMS/Solvay resident essay award. Relationship between estrogen, serotonin, and depression. Menopause. 1999;6:71–78.
    1. Ritchie J, Marouf N, Dion SB, et al. Role of ovarian hormones in the pathogenesis of impaired detrusor contractility: evidence in ovariectomized rodents. J Urol. 2001;166:1136–1141.
    1. Nishizawa S, Benkelfat C, Young SN, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 1997;94:5308–5313.
    1. Longhurst PA, Eika B, Leggett RE, Levin RM. Comparison of urinary bladder function in 6 and 24 month male and female rats. J Urol. 1992;148:1615–1620.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する